Friday, March 9, 2018 News Recap: Canada: Northern Vancouver Island VIRAL HEPATITIS Outreach Roadshow Trip 2018 – March 12 – 21, 2018. We are happy to announce that a 10-day roadtrip to northern Vancouver Island is just around the corner! We will be bringing hot-off-the-press posters, pamphlets, and audio-visual resources to community organizations and Friendship Centres, band health centres, and health clinics. See links to some of the resources we...
People who received kidneys from donors infected with hepatitis C did not become ill with the virus, thanks to treatment with newer drugs that can cure the disease, a small study reports. Ten patients not previously infected with hepatitis C took doses of powerful antiviral medications before and after receiving the transplants. None of the patients developed chronic infections, researchers report online March 6 in the Annals of Internal Medicine. The fin
Friday, January 12, 2018 News Recap: Officials warn customers of London, Ont., nail salon to get tested for HIV, hepatitis B, C. The Middlesex-London Health Unit issued an alert warning clients of Cali Nails in the White Oaks Mall that they should talk to their doctors. A customer who contracted hepatitis B went to the salon for a manicure and pedicure. The advisory is for anyone who visited the salon between May 4, 2017, and Jan. 5, 2018. Dynavax...
Brief: Survival after HCC diagnosis is significantly worse in KTR compared to nontransplanted patients with HBV and/or HCV. Prevention is crucial and should be based on viral eradication/suppression before or after transplantation. PLoS One. 2018 Jan 2;13(1):e0190340. doi: 10.1371/journal.pone.0190340. eCollection 2018. https://www.ncbi.nlm.nih.gov/pubmed/27917563
HealthDay News — For kidney transplant recipients with hepatitis C virus (HCV) genotype 1 or 4 infection, treatment with ledipasvir-sofosbuvir (Harvoni) for 12 or 24 weeks is safe and efficacious, according to a study published online Nov 15 in the Annals of Internal Medicine. Massimo Colombo, MD, from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, and colleagues conducted a randomized phase 2 trial to examine the safety and efficacy
If effective, the new approach could make a dent in the kidney waiting list, where about 5 percent of patients die each year. Last month, Kiran Shelat let University of Pennsylvania surgeons replace his failing kidneys with one that they knew would infect him with hepatitis C, a virus that could slowly destroy his liver. Normally, a kidney infected with hep C would be offered only to transplant patients who already have the disease -- or thrown away.
Researchers at two universities will target diabetic patients over 60 who have more recently been placed on the waiting list for a kidney donor.Since it was shown hepatitis C could be spread through organ transplants 25 years ago, doctors have shied away from using kidneys from people with the infection -- even to transplant the organs to others with hepatitis C. With drugs available that treat the infection with 95 percent efficacy rates, doctors now feel